1. Home
  2. FNGR vs LSTA Comparison

FNGR vs LSTA Comparison

Compare FNGR & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FingerMotion Inc.

FNGR

FingerMotion Inc.

HOLD

Current Price

$0.18

Market Cap

18.9M

Sector

Technology

ML Signal

HOLD

Logo Lisata Therapeutics Inc.

LSTA

Lisata Therapeutics Inc.

HOLD

Current Price

$1.07

Market Cap

15.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FNGR
LSTA
Founded
2016
1980
Country
Singapore
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Misc Health and Biotechnology Services
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.9M
15.9M
IPO Year
2014
2000

Fundamental Metrics

Financial Performance
Metric
FNGR
LSTA
Price
$0.18
$1.07
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 9.1M
243.1K
Earning Date
10-27-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 20.42
EPS
★ N/A
N/A
Revenue
$24,132,261.00
★ $35,283,868.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 56.90
52 Week Low
$0.13
$0.98
52 Week High
$1.74
$5.07

Technical Indicators

Market Signals
Indicator
FNGR
LSTA
Relative Strength Index (RSI) 48.44 33.76
Support Level $0.15 $0.99
Resistance Level $0.37 $1.28
Average True Range (ATR) 0.02 0.12
MACD 0.00 -0.03
Stochastic Oscillator 29.12 11.02

Price Performance

Historical Comparison
FNGR
LSTA

About FNGR FingerMotion Inc.

FingerMotion Inc is engaged in the provision of mobile payment and recharge services in the Chinese market. The Company organizes its operations across four primary areas: telecommunications products and services, marketplace platform and digital commerce infrastructure solutions, data and analytics platform solutions, and Advanced Technology And Platform Solutions. The company generates majority of revenue from telecommunications products and services segment. This segment includes mobile payment and recharge services, as well as enterprise messaging services such as short message services (SMS) and multimedia messaging services (MMS).

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.

Share on Social Networks: